Online citations, reference lists, and bibliographies.

Exploring The Linkage Between Cell Culture Process Parameters And Downstream Processing Utilizing A Plackett‐burman Design For A Model Monoclonal Antibody

Cyrus D Agarabi, Brittany Chavez, Scott Lute, Erik K. Read, Sarah Rogstad, David Awotwe-Otoo, Matthew R Brown, Michael T. Boyne, Kurt Brorson
Published 2017 · Chemistry, Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Linkage of upstream cell culture with downstream processing and purification is an aspect of Quality by Design crucial for efficient and consistent production of high quality biopharmaceutical proteins. In a previous Plackett-Burman screening study of parallel bioreactor cultures we evaluated main effects of 11 process variables, such as agitation, sparge rate, feeding regimens, dissolved oxygen set point, inoculation density, supplement addition, temperature, and pH shifts. In this follow-up study, we observed linkages between cell culture process parameters and downstream capture chromatography performance and subsequent antibody attributes. In depth analysis of the capture chromatography purification of harvested cell culture fluid yielded significant effects of upstream process parameters on host cell protein abundance and behavior. A variety of methods were used to characterize the antibody both after purification and buffer formulation. This analysis provided insight in to the significant impacts of upstream process parameters on aggregate formation, impurities, and protein structure. This report highlights the utility of linkage studies in identifying how changes in upstream parameters can impact downstream critical quality attributes. © 2016 American Institute of Chemical Engineers Biotechnol. Prog., 33:163-170, 2017.
This paper references
10.1002/btpr.1581
Host cell protein adsorption characteristics during protein A chromatography.
Richard D R Tarrant (2012)
10.1080/00207284.2000.11491018
Group
Priscilla F. Kauff (2000)
10.1002/bit.25158
Identification and characterization of host cell protein product-associated impurities in monoclonal antibody bioprocessing.
Nicholas E Levy (2014)
10.1002/btpr.1610
Chemometrics applications in biotechnology processes: predicting column integrity and impurity clearance during reuse of chromatography resin.
Anurag Singh Rathore (2012)
10.1016/j.procbio.2011.10.009
Identification of cell culture conditions to control protein aggregation of IgG fusion proteins expressed in Chinese hamster ovary cells
Ying Jing (2012)
10.1021/bk-2013-1125
Developments in Biotechnology and Bioprocessing
Anne Kantardjieff (2013)
Advances in monoclonal antibody purification
J Wealand (2010)
10.1002/jps.23244
Managing uncertainty: a perspective on risk pertaining to product quality attributes as they bear on immunogenicity of therapeutic proteins.
Amy S. Rosenberg (2012)
10.1002/jps.24420
Bioreactor process parameter screening utilizing a Plackett-Burman design for a model monoclonal antibody.
Cyrus D Agarabi (2015)
10.1021/jp111156z
Understanding the role of arginine as an eluent in affinity chromatography via molecular computations.
Diwakar Shukla (2011)
10.1002/bit.10472
Effect of shear stress on expression of a recombinant protein by Chinese hamster ovary cells.
J. Timothy Keane (2003)
10.1021/bp025715f
Effect of shear stress on intrinsic CHO culture state and glycosylation of recombinant tissue-type plasminogen activator protein.
Ryan S. Senger (2003)
10.1002/bit.22764
Defining process design space for monoclonal antibody cell culture.
Susan Fugett Abu-Absi (2010)
10.1002/btpr.2155
Fermentanomics: Relating quality attributes of a monoclonal antibody to cell culture process variables and raw materials using multivariate data analysis.
Anurag Singh Rathore (2015)
10.1002/btpr.392
Advances in clone selection using high-throughput bioreactors.
Bhargavi Kondragunta (2010)
10.1002/btpr.1948
A Novel Approach to Monitor Clearance of Host Cell Proteins Associated With Monoclonal Antibodies
Nabila Aboulaich (2014)
10.1002/btpr.1728
Fermentanomics informed amino acid supplementation of an antibody producing mammalian cell culture.
Erik K. Read (2013)
10.1002/jps.24522
Comparison of Traditional 2-AB Fluorescence LC-MS/MS and Automated LC-MS for the Comparative Glycan Analysis of Monoclonal Antibodies.
John E. Schiel (2015)
10.1208/aapsj080359
Effects of protein aggregates: An immunologic perspective
Amy S. Rosenberg (2006)
10.1021/bp0342405
Quantitative studies of cell-bubble interactions and cell damage at different pluronic F-68 and cell concentrations.
Ningning Ma (2004)
10.1016/j.molimm.2010.02.018
Circular Dichroism reveals evidence of coupling between immunoglobulin constant and variable region secondary structure.
Alena Janda (2010)
10.1002/bit.24383
Host cell protein dynamics in the supernatant of a mAb producing CHO cell line.
Andrew S. Tait (2012)
10.1038/nbt0109-26
Quality by design for biopharmaceuticals
Anurag Singh Rathore (2009)
10.1074/jbc.M110.204362
In Vivo Crystallization of Human IgG in the Endoplasmic Reticulum of Engineered Chinese Hamster Ovary (CHO) Cells
Haruki Hasegawa (2011)
10.1155/2016/2074149
Improved Stability of a Model IgG3 by DoE-Based Evaluation of Buffer Formulations
Brittany Chavez (2016)
Murine immune response to the Neisseria meningitidis group C capsular polysaccharide. II. Specificity.
Leonard J. Rubinstein (1988)
10.1016/0168-1656(95)00017-K
The effect of fatty acids on hybridoma cell growth and antibody productivity in serum-free cultures.
Michael L. Butler (1995)
10.1002/bit.25286
CHOPPI: A Web Tool for the Analysis of Immunogenicity Risk from Host Cell Proteins in CHO-Based Protein Production
Chris Bailey-Kellogg (2014)
10.1002/bit.23031
Understanding the intracellular effect of enhanced nutrient feeding toward high titer antibody production process.
Marcella Yu (2011)
10.1016/j.copbio.2014.06.017
Measurement and control of host cell proteins (HCPs) in CHO cell bioprocesses.
Catherine E M Hogwood (2014)



This paper is referenced by
10.1016/j.xphs.2019.09.008
Quality by Design Driven Process Development of severe fever with thrombocytopenia syndrome Vaccine.
Xinran Li (2019)
10.1016/j.biotechadv.2018.03.021
Host cell protein removal from biopharmaceutical preparations: Towards the implementation of quality by design.
Cher Hui Goey (2018)
10.1002/btpr.2805
Identification of upstream culture conditions and harvest time parameters that affect host cell protein clearance.
Louisa Wilson (2019)
10.1007/s00216-020-02407-z
A critical review of recent trends, and a future perspective of optical spectroscopy as PAT in biopharmaceutical downstream processing
Laura Rolinger (2020)
10.1002/btpr.2575
Impact of media and antifoam selection on monoclonal antibody production and quality using a high throughput micro‐bioreactor system
Sai Rashmika Velugula-Yellela (2018)
10.1016/j.jpba.2018.09.008
An ICP‐MS platform for metal content assessment of cell culture media and evaluation of spikes in metal concentration on the quality of an IgG3:&kgr; monoclonal antibody during production
Adil Mohammad (2019)
10.1007/s00253-020-10596-x
Performance of an acoustic settler versus a hollow fiber–based ATF technology for influenza virus production in perfusion
Gwendal Gränicher (2020)
10.1016/j.xphs.2019.02.004
Quality by Design-Driven Process Development of Cell Culture in Bioreactor for the Production of Foot-And-Mouth Veterinary Vaccine.
Xinran Li (2019)
10.1002/bit.26383
Opportunities and challenges of real-time release testing in biopharmaceutical manufacturing.
Mo Jiang (2017)
10.1007/s10295-017-1913-4
Advancement in bioprocess technology: parallels between microbial natural products and cell culture biologics
Arpan A Bandyopadhyay (2017)
Semantic Scholar Logo Some data provided by SemanticScholar